As of 2024-12-12, the Intrinsic Value of Spero Therapeutics Inc (SPRO) is
5.55 USD. This SPRO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 1.15 USD, the upside of Spero Therapeutics Inc is
382.60%.
The range of the Intrinsic Value is 4.92 - 6.49 USD
SPRO Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
a |
DCF (Growth 5y) |
4.92 - 6.49 |
5.55 |
382.6% |
DCF (Growth 10y) |
5.62 - 7.42 |
6.34 |
451.6% |
DCF (EBITDA 5y) |
7.05 - 8.75 |
7.93 |
589.3% |
DCF (EBITDA 10y) |
7.37 - 9.45 |
8.39 |
629.6% |
Fair Value |
1.39 - 1.39 |
1.39 |
21.05% |
P/E |
1.39 - 7.36 |
4.43 |
285.7% |
EV/EBITDA |
1.13 - 8.93 |
4.61 |
300.5% |
EPV |
(2.82) - (4.04) |
(3.43) |
-398.2% |
DDM - Stable |
0.30 - 0.58 |
0.44 |
-61.9% |
DDM - Multi |
1.90 - 3.06 |
2.36 |
104.9% |
SPRO Intrinsic Value - Key Valuation Metrics
Market Cap (mil) |
62.70 |
Beta |
1.27 |
Outstanding shares (mil) |
54.52 |
Enterprise Value (mil) |
-13.59 |
Market risk premium |
4.60% |
Cost of Equity |
13.11% |
Cost of Debt |
5.00% |
WACC |
8.39% |